组胺2受体：治疗注意力缺陷多动障碍的新靶点。
Histamine 2 receptor: Emerging target for the treatment of attention-deficit/hyperactivity disorder.
作者信息
Shan Ling, Swaab Dick F
机构信息
Department Neuropsychiatric Disorders, Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, the Netherlands.
Department Neuropsychiatric Disorders, Netherlands Institute for Neuroscience, an Institute of the Royal Netherlands Academy of Arts and Sciences, Amsterdam, the Netherlands.
出版信息
Cell Rep Med. 2025 Mar 18;6(3):102023. doi: 10.1016/j.xcrm.2025.102023.
A study by An et al. sheds a novel light on the potential role of histamine 2 receptor (HR) deficiency in attention-deficit/hyperactivity disorder (ADHD), which could be a future therapeutic target of ADHD. This spotlight provides an overview of the current knowledge of the histaminergic system and proposes future directions.
安等人的一项研究为组胺2受体（HR）缺乏在注意力缺陷多动障碍（ADHD）中的潜在作用带来了新的启示，这可能成为ADHD未来的治疗靶点。本综述概述了组胺能系统的现有知识，并提出了未来的研究方向。
Zotero 插件